WallStreetZenWallStreetZen

NASDAQ: CGON
Cg Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CGON

Based on 8 analysts offering 12 month price targets for Cg Oncology Inc

Min Forecast
$47.00-26.89%
Avg Forecast
$73.00+13.55%
Max Forecast
$90.00+39.99%

Should I buy or sell CGON stock?

Based on 8 analysts offering ratings for Cg Oncology Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CGON's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates CGON as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their CGON stock forecasts and price targets.

CGON stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-02-27
lockedlocked$00.00+00.00%2026-02-10Find Out Why
lockedlocked$00.00+00.00%2026-01-21
lockedlocked$00.00+00.00%2026-01-16Find Out Why
lockedlocked$00.00+00.00%2025-12-11
Guggenheim
Top 24%
77
Strong BuyInitiates Coverage On$90.00+39.99%2025-10-08
JP Morgan
Top 27%
74
Strong BuyMaintains$47.00-26.89%2025-09-26
Morgan Stanley
Top 8%
93
Strong BuyMaintains$79.00+22.88%2025-09-17Find out why

1 of 1

Forecast return on equity

Is CGON forecast to generate an efficient return?

Company
30.5%
Industry
66.31%
Market
181.06%
CGON's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CGON forecast to generate an efficient return on assets?

Company
28.99%
Industry
31.93%
CGON is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CGON earnings per share forecast

What is CGON's earnings per share in the next 3 years based on estimates from 17 analysts?

Avg 1 year Forecast
-$2.51
Avg 2 year Forecast
-$2.11
Avg 3 year Forecast
$0.08

CGON revenue forecast

What is CGON's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$24.3M+501.93%
Avg 2 year Forecast
$141.4M+3,399.01%
Avg 3 year Forecast
$472.6M+11,597.28%
CGON's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CGON revenue growth forecast

How is CGON forecast to perform vs Biotechnology companies and vs the US market?

Company
372.98%
Industry
37.67%
Market
13.46%
CGON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CGON's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CGON vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CGON$64.29$73.00+13.55%Strong Buy
MIRM$90.66$121.70+34.24%Strong Buy
COGT$34.00$46.57+36.97%Buy
PTCT$64.49$80.50+24.83%Buy
CELC$114.22$113.29-0.82%Strong Buy
View Top Biotech Stocks

Cg Oncology Stock Forecast FAQ

Is Cg Oncology Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: CGON) stock is to Strong Buy CGON stock.

Out of 8 analysts, 5 (62.5%) are recommending CGON as a Strong Buy, 3 (37.5%) are recommending CGON as a Buy, 0 (0%) are recommending CGON as a Hold, 0 (0%) are recommending CGON as a Sell, and 0 (0%) are recommending CGON as a Strong Sell.

If you're new to stock investing, here's how to buy Cg Oncology stock.

What is CGON's earnings growth forecast for 2026-2028?

(NASDAQ: CGON) Cg Oncology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 36.33%.

Cg Oncology's earnings in 2026 is -$160,995,000.On average, 17 Wall Street analysts forecast CGON's earnings for 2026 to be -$212,295,423, with the lowest CGON earnings forecast at -$275,545,832, and the highest CGON earnings forecast at -$120,573,466. On average, 16 Wall Street analysts forecast CGON's earnings for 2027 to be -$178,276,481, with the lowest CGON earnings forecast at -$246,584,558, and the highest CGON earnings forecast at -$20,391,101.

In 2028, CGON is forecast to generate $7,151,661 in earnings, with the lowest earnings forecast at -$177,077,501 and the highest earnings forecast at $283,702,272.

What is CGON's revenue growth forecast for 2026-2028?

(NASDAQ: CGON) Cg Oncology's forecast annual revenue growth rate of 372.98% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.67%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.46%.

Cg Oncology's revenue in 2026 is $4,040,000.On average, 16 Wall Street analysts forecast CGON's revenue for 2026 to be $2,053,295,194, with the lowest CGON revenue forecast at $0, and the highest CGON revenue forecast at $9,836,700,800. On average, 16 Wall Street analysts forecast CGON's revenue for 2027 to be $11,935,759,872, with the lowest CGON revenue forecast at $2,068,662,400, and the highest CGON revenue forecast at $37,311,070,528.

In 2028, CGON is forecast to generate $39,901,542,464 in revenue, with the lowest revenue forecast at $17,633,447,168 and the highest revenue forecast at $67,999,888,320.

What is CGON's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: CGON) forecast ROA is 28.99%, which is lower than the forecast US Biotechnology industry average of 31.93%.

What is CGON's Price Target?

According to 8 Wall Street analysts that have issued a 1 year CGON price target, the average CGON price target is $73.00, with the highest CGON stock price forecast at $90.00 and the lowest CGON stock price forecast at $47.00.

On average, Wall Street analysts predict that Cg Oncology's share price could reach $73.00 by Feb 27, 2027. The average Cg Oncology stock price prediction forecasts a potential upside of 13.55% from the current CGON share price of $64.29.

What is CGON's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: CGON) Cg Oncology's current Earnings Per Share (EPS) is -$2.08. On average, analysts forecast that CGON's EPS will be -$2.51 for 2026, with the lowest EPS forecast at -$3.26, and the highest EPS forecast at -$1.43. On average, analysts forecast that CGON's EPS will be -$2.11 for 2027, with the lowest EPS forecast at -$2.92, and the highest EPS forecast at -$0.24. In 2028, CGON's EPS is forecast to hit $0.08 (min: -$2.10, max: $3.36).

What is CGON's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: CGON) forecast ROE is 30.5%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.